| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |